Korean J Med.  2014 Aug;87(2):193-199. 10.3904/kjm.2014.87.2.193.

Hybrid Treatment of an Aortic Arch Aneurysm with an Aberrant Right Subclavian Artery

Affiliations
  • 1Division of Cardiology, Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea. glaraone@hanmail.net
  • 2Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.

Abstract

Aberrant right subclavian artery (ARSA) is a rare congenital anomaly but is the most common of the congenital vascular anomalies of the aortic arch. We report the case of a 68-year-old female undergoing chemotherapy for multiple myeloma who had a large thoracic aortic aneurysm (7.4 cm) with ARSA. She was treated with a hybrid procedure that combined a left common carotid-to-subclavian artery bypass with a "thoracic endovascular aortic repair (TEVAR)" because of the risk associated with a thoracotomy. A stent graft was deployed in the proximal part of the descending aorta to cover the thoracic aortic aneurysm after a left common carotid-to-subclavian bypass was made to restore blood flow in the left arm. There was no endoleak on digital subtraction angiography. Hybrid therapy can be performed successfully for the treatment of thoracic aortic aneurysm with ARSA.

Keyword

Aorta; Aortic aneurysm; Stents; Aberrant subclavian artery

MeSH Terms

Aged
Aneurysm*
Angiography, Digital Subtraction
Aorta
Aorta, Thoracic*
Aortic Aneurysm
Aortic Aneurysm, Thoracic
Arm
Arteries
Blood Vessel Prosthesis
Drug Therapy
Endoleak
Female
Humans
Methods
Multiple Myeloma
Stents
Subclavian Artery*
Thoracotomy
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr